Harald Quandt Industriebeteiligungen GmbH (HQIB) has acquired a majority stake in Funke Medical AG.The previous shareholder and executive board member Andreas Funkeand other board members will continue to hold a significant share in the company.
Over the past 16 years, Funke Medical has become the market leader for decubitusprophylaxis and therapy systems in Germany. The high-quality solutions are used for the treatment and prevention of pressure ulcers and other skin damage caused by prolonged immobility of patients. For its products, the company uses proprietary innovative foam formulations and combinations of different foam layers. Funke Medical exports its products to more than 30 countries worldwide.
CODEX Partners prepared the commercial due diligence of Funke Medical for HQIB.
CODEX Partners advises investors on Commercial Due Diligence and Vendor Due Diligence, strategy development, cost optimization and restructuring of portfolio companies and in the development of industry platforms. Investors benefit from our experience from over 500 projects.
